The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Synthetic opioids constitute one of the fastest-growing groups of new psychoactive substances (NPS) worldwide. With fentanyl analogues being increasingly controlled via classwide scheduling, many non-fentanyl-related opioids are now emerging on the recreational opioid market, rendering the landscape highly complex and dynamic. While new compounds are entering the supply in rapid and unpredictable manners, some recent patterns have become apparent. Many of these newly emerging opioids are being pirated from early patent literature and/or research papers, synthesized and sold online through various channels. Burdened by the identification of every newly emerging drug, many toxicology labs struggle to keep up. Moreover, by the time a ‘new’ drug is controlled via legislative measures, illicit drug markets will have already adapted and diversified as manufacturers work to avoid the restricted product(s). Hence, the typical life cycle of an NPS opioid is generally short (less than 6 months to 1 year), with only a few drugs escalating to significant numbers of detections. In this review, we summarize the key events in the emergence, rise and subsequent decline of two non-fentanyl opioids—isotonitazene and brorphine. These two opioids sequentially dominated the NPS opioid market in 2019 and 2020. Both isotonitazene and brorphine remained in circulation for over a year, each contributing to hundreds of deaths and adverse events. By detailing the life cycles of these opioids from their earliest synthesis as described in scientific literature to their subsequent rise and fall on recreational markets, this review illustrates the new characteristic life cycle of synthetic opioids in the ‘post-fentanyl-analogue’ era.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
World Health Organization Technical Report Series
(1972) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/55.3.666 · Cited by 917
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
Kawamoto, H., Ozaki, S., Itoh, Y., Miyaji, M., Arai, S., Nakashima, H., Kato, T., Ohta, H., & Iwasawa, Y. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990517p · Cited by 204
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Self-citationPasin, D., Cawley, A., Bidny, S., & Fu, S. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0441-4 · Cited by 150
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146
Self-citationDARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141
Blanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116
Self-citationKrotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91
Self-citationMueller, F., Bogdal, C., Pfeiffer, B., Andrello, L., Ceschi, A., Thomas, A., & Grata, E. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110686 · Cited by 82
Optimization of a series of mu opioid receptor (MOR) agonists with high G protein signaling bias
Kennedy, N. M., Schmid, C. L., Ross, N. C., Lovell, K. M., Yue, Z., Chen, Y. T., Cameron, M. D., Bohn, L. M., & Bannister, T. D. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01136 · Cited by 71
Hunger, A., Kebrle, J., Rossi, A., & Hoffmann, K. (1960) · Helvetica Chimica Acta · doi:10.1002/hlca.19600430412 · Cited by 70
Krotulski, A. J., Varnum, S. J., & Logan, B. K. (2020) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14184 · Cited by 65
Self-citationIn vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
Vandeputte, M. M., Cannaert, A., & Stove, C. P. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02855-7 · Cited by 65
Self-citationSharma, K. K., Hales, T. G., Rao, V. J., NicDaeid, N., & McKenzie, C. (2019) · Forensic Toxicology · doi:10.1007/s11419-018-0454-5 · Cited by 58
Pharmacological Research as a Key Component in Mitigating the Opioid Overdose Crisis
Baumann, M. H., Kopajtic, T. A., & Madras, B. K. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.09.006 · Cited by 57
Griffiths, P., Evans-Brown, M. J., & Sedefov, R. (2013) · Addiction · doi:10.1111/add.12287 · Cited by 55
The dawn of a new synthetic opioid era: the need for innovative interventions
Pardo, B., Taylor, J., Caulkins, J., Reuter, P., & Kilmer, B. (2021) · Addiction · doi:10.1111/add.15222 · Cited by 51
Bioanalytical Methods for New Psychoactive Substances
Wagmann, L., & Maurer, H. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_83 · Cited by 48
Krotulski, A. J., Papsun, D. M., Noble, C., Kacinko, S. L., & Logan, B. K. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14623 · Cited by 47
Self-citationFirst Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?
Verougstraete, N., Vandeputte, M. M., Lyphout, C., Cannaert, A., Hulpia, F., Van Calenbergh, S., Verstraete, A. G., & Stove, C. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa094 · Cited by 44
Self-citationControl of fentanyl-related substances in China
Bao, Y., Meng, S., Shi, J., & Lü, L. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30218-4 · Cited by 42
Blanckaert, P., Balcaen, M., Vanhee, C., Risseeuw, M., Canfyn, M., Desmedt, B., Van Calenbergh, S., & Deconinck, E. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3113 · Cited by 39
Activity-based reporter assays for the screening of abused substances in biological matrices
Cannaert, A., Vandeputte, M. M., Wille, S. M. R., & Stove, C. P. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1576588 · Cited by 20
Self-citationBowen, D. A., O’Donnell, J. K., & Sumner, S. A. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05255-5 · Cited by 18
Death associated with brorphine, an emerging novel synthetic opioid
Vohra, V., King, A. M., Jacobs, E., & Aaron, C. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1879111 · Cited by 16
Griffiths, P., Mounteney, J., & Sedefov, R. (2021) · Addiction · doi:10.1111/add.15340 · Cited by 3
Research works printed but not linked: 13
- UNODC, 2021, Booklet 2: Global Overview of Drug Demand and Drug Supply
- UNODC, 2019, Understanding the global opioid crisis
- UNODC, 2020, The growing complexity of the opioid crisis
- Hoffmann, 1960, Benzimidazoles
- Hoffmann, 1959, Verfahren zur Herstellung analgetisch wirksamer Benzimidazole
- World Health Organization, 1961, Expert committee on addiction-producing drugs, 1
- EMCDDA, 2020, EMCDDA Initial Report on the New Psychoactive Substance N,N-diethyl-2,4-(1-methylethoxy)phenylmethyl-5-nitro-1H-benzimidazole-1-ethanamine (Isotonitazene)
- Krotulski, 2019, Potent Synthetic Opioid - Isotonitazene - Recently Identified in the Midwestern United States
- EMCDDA, 2019, EMCDDA Operating Guidelines for the European Union Early Warning System on New Psychoactive Substances
- World Health Organization, 2020, 43rd Expert Committee on Drug Dependence (ECDD): Critical Review Report: Isotonitazene
- Janssens, 1967, Derivatives of benzimidazolinyl piperidine
- EMCDDA, 2020, EU Early Warning System Situation Report: Situation Report 1 - June 2020
- World Health Organization, 2021, 44th Expert Committee On Drug Dependence (ECDD): Substances for review 11–15 October 2021
Cited by
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Amaducci, A., Aldy, K., Campleman, S. L., Li, S., Meyn, A., Abston, S., Culbreth, R. E., Krotulski, A., Logan, B., Wax, P., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.31264 · Cited by 84
Self-citationVandeputte, M. M., Krotulski, A. J., Walther, D., Glatfelter, G. C., Papsun, D., Walton, S. E., Logan, B. K., Baumann, M. H., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03276-4 · Cited by 80
Self-citationDe Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
“1, 2), which quickly populated the NSO market and has since been implicated in hundreds of deaths worldwide, stressing the dangerous nature of this family of opioids (EMCDDA 2020; Krotulski et al. 2020; Muel-ler et al. 2021; Vandeputte et al. 2022a; Montanari et al. 2022).”
BackgroundSelf-citationNon-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Metadata
- Authors
- Vandeputte, M. M., Krotulski, A. J., Papsun, D. M., Logan, B. K., & Stove, C. P.
- Affiliations
- Ghent University (BE)
- Fredric Rieders Family Foundation (US)
- NMS Labs, 200 Welsh Rd, Horsham, PA 19044, USA
- Corresponding author
- Stove, Christophe P
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-31
- Volume
- 46
- Issue
- 2
- Pages
- 115-121
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W3180270048
- Semantic Scholar
- eed9ec64ef71540e7665970e3bbbb48d14604f23
- Cited by
- 71
- References
- 28
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 11 · 2023: 17 · 2022: 18 · 2021: 3
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Analytical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek (3S038719, G069419N)
- Bijzonder Onderzoeksfonds UGent (01J15517)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Law › Cybercrime and Law Enforcement Studies
- Keywords
- isotonitazene, synthetic opioids, new psychoactive substances, drug life cycle, illicit drug markets, opioid-related deaths, opioid adverse events, drug scheduling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.